Zhang Hongxia, Jing Zeng, Li Feng, Yue Benming, Zhang Ping, Li Hui
Department of Pharmacy, The Fourth Hospital of Shijiazhuang, Shijiazhuang 050000, China.
Department of Gynecology, The Fourth Hospital of Shijiazhuang, Shijiazhuang 050000, China.
Evid Based Complement Alternat Med. 2022 Jul 12;2022:7730474. doi: 10.1155/2022/7730474. eCollection 2022.
The aim of this study was to explore the clinical effects of metronidazole vaginal effervescent tablets combined with Kushen suppository in the treatment of Trichomonas vaginitis.
Ninety patients with trichomoniasis admitted to our hospital from January 2019 to January 2020 were prospectively analyzed and randomly divided into a control group ( = 45) treated with metronidazole vaginal effervescent tablets and an experimental group ( = 45) treated with Kushen suppository on top of the control group using the random number table method. The clinical effects, inflammatory factors, and microcirculation indexes were compared. We assessed patient's vaginal health by Vaginal Health Score Scale (VHS) before and after treatment and estimated their quality of life according to Generic Quality of Life Inventory-74 (GQOLI-74). A follow-up visit was conducted to compare patient's recurrence 3 months after treatment.
Distinctly higher total clinical effective of the experimental group compared with that of the control group was obtained ( < 0.05); the serum level of inflammatory factors of the experimental group was dramatically lower than that of the control group after treatment ( < 0.001); the experimental group experienced a favorable microcirculation index in comparison with the control group ( < 0.001); superior VHS ( < 0.001) and GQOLI-74 ( < 0.05) scores of the experimental group after treatment compared to those of the control group were observed; the recurrence rate of the experimental group 3 months after treatment was significantly decreased in comparison with that of the control group ( < 0.05).
Metronidazole vaginal effervescent tablets combined with Kushen suppository can effectively improve the clinical symptoms of patients with trichomonas vaginitis, abate patient's inflammatory reaction, and raise their quality of life, which is worthy of promotion.
本研究旨在探讨甲硝唑阴道泡腾片联合苦参栓治疗滴虫性阴道炎的临床效果。
对2019年1月至2020年1月我院收治的90例滴虫病患者进行前瞻性分析,采用随机数字表法将其随机分为对照组(n = 45),采用甲硝唑阴道泡腾片治疗,实验组(n = 45)在对照组基础上加用苦参栓治疗。比较两组的临床疗效、炎症因子及微循环指标。采用阴道健康评分量表(VHS)在治疗前后评估患者的阴道健康状况,并根据生活质量综合评定问卷-74(GQOLI-74)评估患者的生活质量。进行随访,比较治疗后3个月患者的复发情况。
实验组的总临床有效率明显高于对照组(P < 0.05);治疗后实验组血清炎症因子水平明显低于对照组(P < 0.001);实验组的微循环指标优于对照组(P < 0.001);治疗后实验组的VHS评分(P < 0.001)和GQOLI-74评分(P < 0.05)均高于对照组;治疗后3个月实验组的复发率明显低于对照组(P < 0.05)。
甲硝唑阴道泡腾片联合苦参栓可有效改善滴虫性阴道炎患者的临床症状,减轻患者的炎症反应,提高患者的生活质量,值得推广。